Screener
Corcept Therapeutics CORT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of property and equipment | (2,729) | (161) |
| Proceeds from sales and maturities of marketable securities | 119,312 | 205,536 |
| Purchases of marketable securities | (141,283) | (138,419) |
| Net cash (used in) provided by investing activities | (24,700) | 66,956 |
| Cash flows from financing activities: | ||
| Proceeds from stock option exercises, net of issuance costs | 9,741 | 10,975 |
| Proceeds from purchases under the Employee Stock Purchase Program | 6,200 | 4,990 |
| Repurchases of common stock in connection with Stock Repurchase Program | — | (130,451) |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's investing cash flow?
- Corcept Therapeutics (CORT) reported investing cash flow of -$29.24M in Q2 2026.
- How has Corcept Therapeutics's investing cash flow changed year-over-year?
- Corcept Therapeutics's investing cash flow decreased by 141.7% year-over-year, from $70.13M to -$29.24M.
- What is the long-term trend for Corcept Therapeutics's investing cash flow?
- Over 2 years (2021 to 2024), Corcept Therapeutics's investing cash flow has grown at a 14.2% compound annual growth rate (CAGR), from $136.13M to -$177.6M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Corcept Therapeutics's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude